Key result
Diastolic dysfunction linked to ~3.5-fold higher mortality in sickle cell disease.
Why the study?
The prevalence of diastolic dysfunction, its association with pulmonary hypertension, and its impact on mortality in patients with sickle cell disease were unknown.
Population
235 patients with sickle cell disease
Comparison
Patients with diastolic dysfunction vs without diastolic dysfunction
Design
Cohort study with echocardiographic assessment
Authors
Loading...
Cohort study reveals diastolic dysfunction independently predicts mortality in sickle cell disease, indicating the need for routine echocardiographic screening.
Cohort (n=235)
Relative Risk: 3.5 (95% CI 1.5–8.4)
p-value: p=< 0.001
Sachdev et al. (2007) conducted a cohort in Sickle cell disease (n=235). Diastolic dysfunction vs. Normal diastolic function was evaluated on Mortality (RR 3.5, 95% CI 1.5 to 8.4, p=< 0.001). Diastolic dysfunction was independently associated with mortality in patients with sickle cell disease (RR 3.5; 95% CI 1.5 to 8.4; p < 0.001).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: